Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plecanatide in Irritable Bowel Syndrome With Constipation (IBS-C)
NCT02387359Phase 3Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of plecanatide in irritable bowel syndrome (IBS), sponsored by Valeant Pharmaceuticals. Started Dec 2014; status: completed.
02
Drugs
plecanatide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02387359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387359.